Remel, Inc.
$16.5K 11 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Accufix Surgical Inc.
Accufix Surgical Inc. reported $16,433.32 across General Payments, Research, and Ownership to 30 physicians and teaching hospitals across 30 transactions.
- $16.4K Below-median payer
- All-tracks total
- 30 Below-median volume
- Transactions
- 30 Below-median reach
- Recipients
- −$7.1K
- General Payments vs PY2023
Accufix Surgical Inc. reported $16,433.32 across all CMS Open Payments tracks (General + Research + Ownership) to 30 physicians and teaching hospitals in Program Year 2024 - ranking #1567 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $16,433.32, averaging $547.78 per recipient.
How Accufix Surgical Inc.'s $16.4K all-tracks total breaks down
Accufix Surgical Inc.'s payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
17/100
Total payments
F
10/100
Transaction volume
F
10/100
Physician reach
F
10/100
Payment type diversity
F
37/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer accufix-surgical-inc Accufix Surgical Inc.
$16.4K · #1567/1,925 · 0.0% industry · PY2024
- TOT $16.4K
- RANK #1567
- SHARE 0.0%
- TXN 30
- RCP 30
- CAT 3
- GEN $16.4K
- ΔGEN −$7.1K
- TOP1 83.1%
- PY 2024
Volume peers
Nearest volume peer: Remel, Inc. ($16.5K)
Accufix Surgical Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Accufix Surgical Inc.'s CMS-reported General Payments decreased by $7.1K (−30.2%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: ACCUFIX SURGICAL INC.PY2023: ACCUFIX SURGICAL INC.PY2024: Accufix Surgical Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $23,542.04
- PY2024
- $16,433.32
What the Data Shows for Accufix Surgical Inc.
Three separate CMS disclosure tracks feed the all-tracks total above - General, Research, and Ownership/Investment - each reported under its own rules and combined here for one comparable figure. For Accufix Surgical Inc., that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. CMS releases each Program Year roughly 12 months after it ends; the methodology page covers the full standardization basis.
"Consulting Fee" leads the 3-category general-payment breakdown below at $13.5K (82.1% of General Payments, 7 transactions) - see our methodology for how research and ownership payments are reported separately.
General Payment Breakdown by Type
Across 3 types of general payments, Accufix Surgical Inc.'s largest category was "Consulting Fee" at $13.5K - 82.1% of General Payments.
How Accufix Surgical Inc. divides its payments
Top payment categories by total reported dollar volume
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Consulting Fee | $13.5K | 7 | 82.1% |
| Travel and Lodging | $1.8K | 3 | 11.0% |
| Food and Beverage | $1.1K | 20 | 6.9% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $15,761.06 (95.9%) of $16,433.32 in this company's General Payments records across 19 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Accufix Surgical Inc.
The five named recipients with the highest reported General Payments from this company
- 1
William Sarchino
$13,661.92 across 10 reported transactions
- 2
Kyle Vaughn
$1,774.12 across 2 reported transactions
- 3
Stephen Arndt
$165.20 across 2 reported transactions
- 4
Erin Koprince
$79.91 across 1 reported transactions
- 5
Mona Ramani
$79.91 across 1 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Accufix Surgical Inc. ranks #1567 of 1,925 by total payments (bottom 19% by spend) but is notably more concentrated than that alone would suggest -- #227 of 1,838 by HHI (top 12% most concentrated). Its payments land on an unusually narrow set of recipients for its spend size.
View all 12 companies in this HHI neighborhood as a list
- Mission Pharmacal Company : $82.4K total payments, HHI 7251
- Illumina, Inc. : $4.0M total payments, HHI 7249
- The Walman Optical Company : $47.1K total payments, HHI 7106
- Sebela Women's Health Inc. : $156.8K total payments, HHI 7064
- Vero Biotech Inc. : $4.4K total payments, HHI 7058
- Vital Connect, Inc : $141.5K total payments, HHI 7052
- Accufix Surgical Inc. (this company) : $16.4K total payments, HHI 7031
- Genentech, Inc. : $59.4M total payments, HHI 6977
- Surgi-Care, Inc. : $31.9K total payments, HHI 6940
- Myomo, Inc : $9.3K total payments, HHI 6932
- Heidelberg Engineering, Inc. : $361.5K total payments, HHI 6929
- Potrero Medical, Inc. : $33.9K total payments, HHI 6915
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Accufix Surgical Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Accufix Surgical Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Accufix Surgical Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
InfoBionic, Inc
$16.6K 66 recipients
Compare payment profiles
MedOne Surgical Inc
$16.7K 16 recipients
Compare payment profiles
Nidek Incorporated
$16.8K 3 recipients
Compare payment profiles
Monaghan Medical Corporation
$16.0K 224 recipients
Compare payment profiles
Pfizer Chile S.a.
$16.9K 5 recipients
Compare payment profiles
Put this to use
Accufix Surgical Inc. ranks #1567 of 1,925 by all-tracks total payments, led by "Consulting Fee".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Consulting Fee" spend across every manufacturer, not just Accufix Surgical Inc.. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.